OXALIPLATINE Sandoz conc perf 100 mg/20ml vial
7680616630056
CH-61663
L01XA03
07.16.1.
1 / 3
google
Details
- Product number
- 6166302
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- oxaliplatinum 100 mg, aqua ad iniectabile q.s. ad solutionem pro 20 ml.
Articles (1)
Oxaliplatin Sandoz 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 182.55
Specialties list
Yes
Generic
Yes
SL addition date:
01/07/2011
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 61663
- Drug name
- Oxaliplatin Sandoz, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/04/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OXALIPLATINE Sandoz conc perf 100 mg/20ml vial
- Description (DE)
- OXALIPLATIN Sandoz Inf Konz 100 mg/20ml Vial
- Market launch
- 15/04/2011
- Narcotic (BTM)
- No